Codexis SEC Filings

Type
Report
Date
4Insidertransaktion2/9/2026
4Insidertransaktion2/9/2026
4Insidertransaktion2/9/2026
144144-Formular2/6/2026
144144-Formular2/6/2026
SCHEDULE 13G/ASCHEDULE 13G/A-Formular1/23/2026
144144-Formular1/16/2026
SCHEDULE 13G/ASCHEDULE 13G/A-Formular1/15/2026
4Insidertransaktion1/8/2026
144144-Formular1/7/2026
4/A4/A-Formular12/15/2025
4/A4/A-Formular12/15/2025
SCHEDULE 13G/ASCHEDULE 13G/A-Formular12/5/2025
4Insidertransaktion12/1/2025
4Insidertransaktion11/25/2025
144144-Formular11/21/2025
4Insidertransaktion11/17/2025
33-Formular11/17/2025
SCHEDULE 13G/ASCHEDULE 13G/A-Formular11/14/2025
4Insidertransaktion11/14/2025
4Insidertransaktion11/13/2025
4Insidertransaktion11/12/2025
4Insidertransaktion11/12/2025
SCHEDULE 13G/ASCHEDULE 13G/A-Formular11/7/2025
10-QQuartalsbericht11/6/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/6/2025
SCHEDULE 13G/ASCHEDULE 13G/A-Formular11/5/2025
4Insidertransaktion10/15/2025
4Insidertransaktion10/15/2025
144144-Formular10/14/2025
144144-Formular10/14/2025
SCHEDULE 13G/ASCHEDULE 13G/A-Formular8/14/2025
S-8S-8-Formular8/13/2025
10-QQuartalsbericht8/13/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben8/13/2025
4Insidertransaktion8/4/2025
4Insidertransaktion7/31/2025
SCHEDULE 13GSCHEDULE 13G-Formular7/30/2025
4Insidertransaktion7/22/2025
4Insidertransaktion7/1/2025
4Insidertransaktion6/16/2025
4Insidertransaktion6/12/2025
4Insidertransaktion6/12/2025
4Insidertransaktion6/12/2025
4Insidertransaktion6/12/2025
4Insidertransaktion6/12/2025
4Insidertransaktion6/12/2025
4Insidertransaktion6/12/2025
4Insidertransaktion6/12/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben6/11/2025
4Insidertransaktion5/28/2025
10-QQuartalsbericht5/14/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben5/14/2025
4Insidertransaktion5/2/2025
4Insidertransaktion4/29/2025
DEFA14ADEFA14A-Formular4/24/2025
DEF 14ADEF 14A-Formular4/24/2025
SCHEDULE 13G/ASCHEDULE 13G/A-Formular4/24/2025
4Insidertransaktion4/17/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben4/9/2025
4Insidertransaktion4/9/2025
4Insidertransaktion4/3/2025
33-Formular4/1/2025
4Insidertransaktion4/1/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben3/31/2025
4Insidertransaktion3/24/2025
4Insidertransaktion3/14/2025
4Insidertransaktion3/10/2025
4Insidertransaktion3/6/2025
4Insidertransaktion3/4/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/27/2025
10-KJahresbericht2/27/2025
4Insidertransaktion2/12/2025
4Insidertransaktion2/7/2025
4Insidertransaktion2/7/2025
4Insidertransaktion2/7/2025
4Insidertransaktion2/7/2025
4Insidertransaktion1/31/2025
4Insidertransaktion1/16/2025
33-Formular1/16/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1/16/2025
4Insidertransaktion1/2/2025
SCHEDULE 13G/ASCHEDULE 13G/A-Formular11/14/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/12/2024
4Insidertransaktion11/12/2024
33-Formular11/12/2024
10-QQuartalsbericht10/31/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10/31/2024
4Insidertransaktion10/28/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10/22/2024
4Insidertransaktion10/10/2024
33-Formular10/10/2024
4Insidertransaktion10/10/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10/2/2024
SC 13GSC 13G-Formular9/26/2024
4Insidertransaktion9/26/2024
4Insidertransaktion9/23/2024
4Insidertransaktion9/19/2024
SC 13G/ABeneficial ownership report9/18/2024
S-8S-8-Formular8/9/2024

Codexis Documents 2026

This page contains all official documents and SEC filings for Codexis stock (CDXS, ISIN: US1920051067). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 100 documents are available. Data is updated regularly to provide investors with a complete overview of Codexis's regulatory filings.

Codexis Stock analysis

Codexis Codexis Inc. is an American biotechnology company that specializes in developing innovative biological solutions for a variety of industries. The company was founded in 2002 and is headquartered in Redwood City, California. Business Model: Codexis is service-oriented and provides customized enzyme solutions for companies looking to improve their products through sustainable processes. The company has developed a unique platform called Rational Protein Engineering, which allows for the development of specific enzymes for various industries. Customers benefit from enzyme optimization expertise and know-how. Divisions: Codexis operates in the fields of life sciences, materials science, agrochemicals, and biofuels. 1. Life Sciences: Codexis specializes in the production of enzymes and biocatalysts for the pharmaceutical industry in the life sciences division. The goal is to provide a faster and more efficient manufacturing process for pharmaceutical active ingredients. The company has successfully developed active ingredients for antibodies, lipids, uric acid, and antivirals. 2. Materials Science: In the materials science division, Codexis specializes in the production of enzymes for materials such as dyes, polymers, and cosmetic products. Codexis ensures that these products are efficiently manufactured without the use of environmentally harmful chemicals. 3. Agrochemicals: Codexis offers customized enzyme solutions to agrochemical manufacturers that reduce the use of chemicals and benefit the environment. These enzymes help in the production of pesticides and other agrochemicals. 4. Biofuels: In the biofuels division, Codexis specializes in the production of enzymes for processing corn, harvested plants, or waste products. These enzymes help enable cost-effective biofuel production. Products: Codexis has developed a wide range of products tailored to the needs of various industries. Some of the products recently introduced to the market by Codexis include: 1. CodeEvolver: CodeEvolver is a platform that allows biotechnology companies to quickly create customized enzyme solutions for their specific needs. The process is fully automated and results in a significant reduction in development time and costs. 2. Codex® screening panels: Codexis offers various screening panels that allow customers to quickly and efficiently select the enzymes best suited for their purposes. The panels are suitable for industries including pharmaceuticals, chemicals, and plant protection. 3. Codex® enzymes: Codexis offers a wide range of enzymes specifically designed for different industry needs. This includes enzymes for the production of biofuels, pesticides, cosmetic products, and pharmaceuticals. Overall, Codexis Inc. has demonstrated its ability to deepen the understanding of biocatalysts and introduce innovative biological processes in a variety of industries through its unique Rational Protein Engineering platform.